Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1988 2
1993 1
1994 1
1996 1
2003 2
2006 1
2007 2
2008 1
2009 2
2012 1
2013 1
2014 2
2016 1
2017 2
2018 2
2019 2
2020 1
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
The emotional impact of the COVID-19 outbreak on cancer outpatients and their caregivers: results of a survey conducted in the midst of the Italian pandemic.
Cona MS, Rulli E, Dalu D, Galli F, Rota S, Ferrario S, Tosca N, Gambaro A, Filipazzi V, Piva S, La Verde N. Cona MS, et al. Among authors: filipazzi v. Support Care Cancer. 2022 Feb;30(2):1115-1125. doi: 10.1007/s00520-021-06489-y. Epub 2021 Aug 25. Support Care Cancer. 2022. PMID: 34432171 Free PMC article.
ABCB1 c.3435C>T polymorphism is associated with platinum toxicity: a preliminary study.
De Troia B, Dalu D, Filipazzi V, Isabella L, Tosca N, Ferrario S, Gambaro AR, Somma L, Fasola C, Cheli S, Clementi E, De Francesco D, Falvella FS, Cattaneo MT. De Troia B, et al. Among authors: filipazzi v. Cancer Chemother Pharmacol. 2019 Apr;83(4):803-808. doi: 10.1007/s00280-019-03794-6. Epub 2019 Feb 22. Cancer Chemother Pharmacol. 2019. PMID: 30796464
Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials.
Morabito A, Piccirillo MC, Maione P, Luciani A, Cavanna L, Bonanno L, Filipazzi V, Leo S, Cinieri S, Morgillo F, Burgio MA, Ferrara D, Rosetti F, Bianco R, Artioli F, Cortinovis D, Gebbia V, Fregoni V, Mencoboni M, Sandomenico C, Rossi A, Montanino A, Manzo A, Rocco G, Arenare L, Daniele G, Signoriello S, Gallo C, Perrone F, Gridelli C. Morabito A, et al. Among authors: filipazzi v. Lung Cancer. 2019 Jul;133:62-68. doi: 10.1016/j.lungcan.2019.05.009. Epub 2019 May 9. Lung Cancer. 2019. PMID: 31200830 Clinical Trial.
Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials.
Gridelli C, Morabito A, Cavanna L, Luciani A, Maione P, Bonanno L, Filipazzi V, Leo S, Cinieri S, Ciardiello F, Burgio MA, Bilancia D, Cortinovis D, Rosetti F, Bianco R, Gebbia V, Artioli F, Bordonaro R, Fregoni V, Mencoboni M, Nelli F, Riccardi F, di Isernia G, Costanzo R, Rocco G, Daniele G, Signoriello S, Piccirillo MC, Gallo C, Perrone F. Gridelli C, et al. Among authors: filipazzi v. J Clin Oncol. 2018 Sep 1;36(25):2585-2592. doi: 10.1200/JCO.2017.76.8390. Epub 2018 Jul 20. J Clin Oncol. 2018. PMID: 30028656 Clinical Trial.
A case of bullous dermatitis induced by erlotinib.
Oteri A, Cattaneo MT, Filipazzi V, Ferrario S, Gambaro A, Isabella L, Tosca N, Clementi E, Radice S, Piazza E. Oteri A, et al. Among authors: filipazzi v. Oncologist. 2009 Dec;14(12):1201-4. doi: 10.1634/theoncologist.2009-0118. Epub 2009 Dec 4. Oncologist. 2009. PMID: 19965913 Free article.
A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial.
Morabito A, Daniele G, Costanzo R, Favaretto AG, Filipazzi V, Rossi A, Gebbia V, Castiglione F, Cavanna L, Maiello E, Sandomenico C, Bonanno L, Piazza E, Maione P, Piccirillo MC, Di Maio M, Rocco G, Gallo C, Perrone F, Gridelli C. Morabito A, et al. Among authors: filipazzi v. Lung Cancer. 2017 Jun;108:15-21. doi: 10.1016/j.lungcan.2017.02.016. Epub 2017 Feb 27. Lung Cancer. 2017. PMID: 28625627 Clinical Trial.
Outcomes of First-Generation EGFR-TKIs Against Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Post Hoc Analysis of the BE-POSITIVE Study.
Pilotto S, Rossi A, Vavalà T, Follador A, Tiseo M, Galetta D, Morabito A, Di Maio M, Martelli O, Caffo O, Piovano PL, Cortinovis D, Zilembo N, Casartelli C, Banna GL, Ardizzoia A, Barzelloni ML, Bearz A, Genestreti G, Mucciarini C, Filipazzi V, Menis J, Rizzo E, Barbieri F, Rijavec E, Cecere F, Spitaleri G, Bria E, Novello S. Pilotto S, et al. Among authors: filipazzi v. Clin Lung Cancer. 2018 Jan;19(1):93-104. doi: 10.1016/j.cllc.2017.05.016. Epub 2017 Jun 1. Clin Lung Cancer. 2018. PMID: 28645631
26 results